Bayer Aktiengesellschaft (ETR:BAYN) Shares Down 1.7% – Here’s What Happened

Bayer Aktiengesellschaft (ETR:BAYN)’s share price traded down 1.7% on Monday . The stock traded as low as €38.69 and last traded at €38.88. 3,534,317 shares changed hands during mid-day trading, The stock had previously closed at €39.54.

Bayer Aktiengesellschaft Stock Performance

The business’s 50 day simple moving average is €32.90 and its 200-day simple moving average is €29.44. The company has a market cap of $39.25 billion, a price-to-earnings ratio of -44.61, a price-to-earnings-growth ratio of 36.39 and a beta of 0.97.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health.